Modified cytosine deaminases
AssigneeRegents of the University of Minnesota
InventorsReuben S. Harris, Hiroshi Matsuo
Life of this patent
Estimating the term…
Abstract
The document provides modified cytosine deaminases with increased solubility and high levels of DNA cytosine deaminase activity.
Claims26
An isolated polypeptide comprising a cytosine deaminase amino acid sequence that aligns with the amino acid sequence set forth in SEQ ID NO:2, wherein said cytosine deaminase amino acid sequence comprises (a) an amino acid other than leucine at the position aligning with position 234 of said amino acid sequence or (b) an amino acid other than phenylalanine at the position aligning with position 310 of said amino acid sequence.
A purified mutant cytosine deaminase polypeptide, wherein said mutant cytosine deaminase polypeptide is catalytically active and has enhanced solubility relative to a corresponding cytosine deaminase.
An isolated nucleic acid encoding a mutant cytosine deaminase polypeptide, wherein said mutant cytosine deaminase polypeptide is catalytically active and has enhanced solubility relative to a corresponding cytosine deaminase having the amino acid sequence set forth in SEQ ID NO:2, SEQ ID NO:4, or SEQ ID NO:6.
A kit comprising a mutant cytosine deaminase polypeptide, wherein said mutant cytosine deaminase polypeptide is catalytically active and has enhanced solubility relative to a cytosine deaminase having the amino acid sequence set forth in SEQ ID NO:2, SEQ ID NO:4, or SEQ ID NO:6.
Dependencies are inferred from the claim text.